Go with the Flow—Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009

Go with the Flow—Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009

Measurable residual disease (MRD) is a well-known tool for the evaluation of the early response to treatment in patients with acute lymphoblastic leukemia (ALL). In respect to predicting the relapse the most informative cut-off and time point of MRD measurement during therapy were evaluated in our s...

Full description

Bibliographic Details
Main Authors: Katarzyna Pawinska-Wasikowska, Karolina Bukowska-Strakova, Marta Surman, Monika Rygielska, Beata Sadowska, Teofila Ksiazek, Tomasz Klekawka, Aleksandra Wieczorek, Szymon Skoczen, Walentyna Balwierz
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
acute lymphoblastic leukemia
minimal or measurable residual disease
blast cell clearance
flow cytometry
children
Online Access:https://www.mdpi.com/2072-6694/14/21/5359

Internet

https://www.mdpi.com/2072-6694/14/21/5359

Similar Items